(CRNC) Cerence - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1567271093
CRNC EPS (Earnings per Share)
CRNC Revenue
CRNC: AI, Virtual, Assistants
Cerence Inc. is a pioneering company that leverages AI to power virtual assistants for the mobility and transportation sector across the globe, including the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. By providing edge software components, cloud-connected components, and professional services, Cerence enables the creation of sophisticated, conversational AI solutions that enhance user experiences in vehicles and other transportation systems.
The companys technology stack includes cutting-edge speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling, allowing for seamless interactions between humans and machines. With its headquarters in Burlington, Massachusetts, Cerence Inc. was established in 2020, marking a significant milestone in the evolution of AI-driven mobility solutions.
From a market perspective, Cerence operates within the Systems Software sub-industry, a sector characterized by rapid innovation and intense competition. The companys financials indicate a market capitalization of $416.87M USD, with a forward P/E ratio of 243.90, suggesting a high growth expectation. However, the negative Return on Equity (RoE) of -289.39 indicates significant challenges in generating profits from shareholder equity.
Analyzing the technical data, CRNCs stock price is currently at $9.29, with short-term moving averages (SMA20: $8.70, SMA50: $8.97) indicating a potential upward trend. The long-term SMA200 at $7.16 suggests a strong support level and a bullish long-term outlook. The Average True Range (ATR) of 0.79, equivalent to 8.52% of the current price, indicates moderate volatility. Given the 52-week high of $20.18 and low of $2.37, the stock has shown significant price swings, presenting both risks and opportunities.
Forecasting CRNCs future performance involves integrating both technical and fundamental data. The bullish trend indicated by the short-term and long-term moving averages, combined with the high growth expectations reflected in the forward P/E ratio, suggests potential for price appreciation. However, the negative RoE and high P/E forward ratio also signal potential risks, including the challenge of meeting high growth expectations and achieving profitability. A prudent forecast would be that CRNCs stock may continue to be volatile, with potential for growth if the company can successfully leverage its AI technology to expand its market share and improve profitability. A key level to watch is the resistance around the 52-week high; breaking through this could signal further upside potential.
Additional Sources for CRNC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CRNC Stock Overview
Market Cap in USD | 365m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | Systems Software |
IPO / Inception | 2019-10-02 |
CRNC Stock Ratings
Growth Rating | -50.9 |
Fundamental | -10.3 |
Dividend Rating | 0.0 |
Rel. Strength | 191 |
Analysts | 3.14 of 5 |
Fair Price Momentum | 8.07 USD |
Fair Price DCF | 9.71 USD |
CRNC Dividends
Currently no dividends paidCRNC Growth Ratios
Growth Correlation 3m | 53.7% |
Growth Correlation 12m | 73.4% |
Growth Correlation 5y | -89.5% |
CAGR 5y | -24.56% |
CAGR/Max DD 5y | -0.25 |
Sharpe Ratio 12m | -0.22 |
Alpha | 223.18 |
Beta | 1.630 |
Volatility | 104.97% |
Current Volume | 3044.1k |
Average Volume 20d | 1703.6k |
As of June 30, 2025, the stock is trading at USD 9.44 with a total of 3,044,104 shares traded.
Over the past week, the price has changed by +8.76%, over one month by +9.77%, over three months by +19.49% and over the past year by +232.39%.
Neither. Based on ValueRay´s Fundamental Analyses, Cerence is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.31 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRNC is around 8.07 USD . This means that CRNC is currently overvalued and has a potential downside of -14.51%.
Cerence has received a consensus analysts rating of 3.14. Therefor, it is recommend to hold CRNC.
- Strong Buy: 0
- Buy: 1
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CRNC Cerence will be worth about 9.3 in June 2026. The stock is currently trading at 9.44. This means that the stock has a potential downside of -1.59%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 11.2 | 18.3% |
Analysts Target Price | 11.2 | 18.3% |
ValueRay Target Price | 9.3 | -1.6% |